Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization
Clinical trial NCT04065737 · UNKNOWN
Trial details
- NCT number
- NCT04065737
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-15
- Primary completion
- 2022-07-15
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.